Aligos Therapeutics, Inc. — DEF 14A Filings
5 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by Aligos Therapeutics, Inc. (ALGS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aligos Therapeutics, Inc. has filed 5 DEF 14A documents with the SEC since 2020. To view all SEC filings by Aligos Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
3
4
424B3
424B4
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001193125-25-100453 | Apr 28, 2025 | Jun 25, 2025 |
| DEF 14A | DEF 14A | 0001193125-24-122181 | Apr 29, 2024 | Jun 27, 2024 |
| DEF 14A | DEF 14A | 0001193125-23-127382 | Apr 28, 2023 | Jul 20, 2023 |
| DEF 14A | DEF 14A | 0001193125-22-129730 | Apr 29, 2022 | Jun 23, 2022 |
| DEF 14A | DEF 14A | 0001193125-21-134253 | Apr 27, 2021 | Jun 17, 2021 |